Oncology Intelligence is an innovation we pioneered, driven by our belief that AI can be the driving force behind the future of oncology research and diagnostics.
CanvOI, a state-of-the-art vision foundation model, developed in collaboration with Oracle and the Ellison Institute of Technology, is set to be a driving force for groundbreaking advancements in cancer research.
Our OI Suite, powered by CanvOI, empowers cancer researchers to generate novel insights and cutting-edge applications by developing AI models, explaining key tissue features driving predictions, and unlocking deep data insights - all without the need for AI expertise or vast datasets.
CanvOI surpasses leading AI models in digital pathology and we believe this breakthrough will accelerate medical research, drive new discoveries and propel drug development.
